Marvell Technology Inc. (MRVL)

Marvell Technology rose 9.33% on November 11, 2026, a session Trefis tied to CoreWeave's earnings update, which it said eased concerns about returns on AI spending; the company released no earnings report that day. The move came after a sharp drawdown: the stock is 48.83% below its 52-week high of $329.88 and 26.95% below its 50-day moving average, with the trend read as down against both the 50-day and 200-day averages. Analysts remain strongly positive, with 38 of 43 rating it Buy, while CleaRank's own score sits at 53/100 and is more cautious than Wall Street.

Trefis reported that Marvell rose 9.3% on November 11, 2026, and tied the move to CoreWeave's earnings update, which it said eased concerns about whether AI spending would pay off. Trefis also noted that the company released no earnings report that day, so the move reflected sector sentiment rather than company results. The gain was large against the stock's recent pattern: its typical daily move over the 60 sessions before was 3.42%.

The one-month return is down 36.51%, and the stock closed on November 11 at $168.80, which is 46.65% below its highest close of the last 252 trading days, $316.43 on June 4, 2026. The last earlier day it closed that far below its high was September 11, 2025. Over the past year the stock is still up 88.96%, so the drawdown is recent and steep rather than a reversal of the full advance.

On November 3, 2026, TD Cowen cut its rating on Marvell from Buy to Hold and lowered its price target from $350 to $175, according to MarketBeat. Wells Fargo and Cantor Fitzgerald also reduced their targets that week, the same report said. Wells Fargo, RBC Capital, Susquehanna and B. Riley Securities kept their ratings that period, and B. Riley kept its Buy rating again on November 9. Of 43 analysts with a current rating, 38 rate it Buy or Strong Buy, five rate it Hold and none rate it Sell. Three months ago, 39 of 44 ratings were Buy.

The trailing P/E is 50.84, a premium to the sector median of 35.1, and the price-to-sales ratio of 16.07 compares with a sector median of 7.6. The August 27, 2026 report beat by 1.08% with EPS of $0.94 against $0.93 expected, yet the stock fell 10.28% in the first session after it. Revenue grew 36.5% in the latest quarter year on year, faster than the sector median of 24.2%. The earnings record is steadier than the price reaction suggests. The share price fell in the first session after four of those eight reports and rose after four, so a beat has not reliably translated into a higher price.

The base case is a stock that stays volatile and works back toward its moving averages before any sustained recovery. Its typical daily move is 6.49% and its beta is 2.33, so swings in either direction will be large relative to the broader market. For the bullish case to take hold, the price needs to reclaim the 200-day average and then the 20-day average, and the planned Lumentum deal would need to close without disrupting the core business. The bearish case is that the price fails at the 200-day average and the momentum readings stay weak. Analysts' median 12-month target is $300.00, with a range from $175.00 to $450.00; TD Cowen's cut to $175.00 sits at the bottom of that range, and the analysts' forecasts for this fiscal year assume EPS growth of 48.7%. Those targets are the analysts' forecasts, not CleaRank's, and the gap between them and the price depends on whether that earnings growth arrives on schedule.

Nearest support is the 52-week low at $70.69, the floor of a range that the stock has not revisited in the past year. Resistance is layered closer to the price: the 200-day simple moving average at $186.22 is the first level a rally would meet, followed by the 20-day exponential moving average at $193.63. Above those sits the 50-day simple moving average at $231.09, which the stock has been trading well beneath, and the 52-week high of $329.88 at the top of the range.